Although no significant differences were observed in CD95 MFI values between ERA, established RA and controls, CD95 expression significantly increased in RA patients after TNF-inhibitors, but not after tocilizumab treatment (Fig 6). The gene discussed is FAS; the disease is rheumatoid arthritis.